You are on page 1of 3

Global Exocrine Pancreatic Insufficiency Diagnostics Market $2.

5 Billion by 2021

Exocrine Pancreatic Insufficiency Diagnostics Market Analysis and Forecast 2017-2021 report estimates the global
exocrine pancreatic insufficiency diagnostics market to reach nearly $2.5 Billion in 2021, at a CAGR of 8.9% from
2017 to 2021 - iHealthcareAnalyst, Inc.

The global exocrine pancreatic insufficiency diagnostics market segmentation is based on diagnostic test types
(blood tests, endoscopic ultra-sonography, magnetic resonance imaging, CT scanning). The global exocrine
pancreatic insufficiency diagnostics market report provides market size (Revenue $Million 2014 to 2021), market
share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).

The global exocrine pancreatic insufficiency diagnostics market research report is divided by geography (regional
and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K.,
Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Visit the Exocrine Pancreatic Insufficiency Diagnostics Market Analysis and Forecast 2017-2021 report
https://www.ihealthcareanalyst.com/report/exocrine-pancreatic-insufficiency-diagnostics-market/

1. Test Type
1.1 Blood Tests
1.2 Endoscopic Ultra-Sonography (EUS)
1.3 Magnetic Resonance Imaging (MRI)
1.4 CT Scanning

2. Geography (Region, Country)


2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbvie Inc.
3.2 Allergan plc.
3.3 Anthera Pharmaceuticals Inc.
3.4 AzurRx BioPharma, Inc.
3.4 Cilian AG
3.6 Digestive Care,Inc.
3.7 Nordmark Arzneimittel GmbH & Co. KG
3.8 Janssen Pharmaceuticals Inc.

To request Table of Contents and Sample Pages of this report visit:


https://www.ihealthcareanalyst.com/report/exocrine-pancreatic-insufficiency-diagnostics-market/

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis,
and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting
grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics,
healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view
of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com